TECHBASE MED DEFENSE (APPLIED RESEARCH)
Abstract
Project TM2 provides for applied research for innovative technology approaches to advance medical systems designed to rapidly identify, diagnose, prevent, and treat disease due to exposure to all three of radiological, chemical and biological threat agents. Categories for this project include core science efforts in Medical Chemical, Medical Biological, Diagnostics, and the Medical Countermeasures Initiative (MCMI). Against radiological threats, this project provides investment for the development of pretreatments (prophylaxis) and post-irradiation therapeutics against radiological/nuclear exposure. Against chemical and biological agents, this project funds applied research for the investigation of new medical countermeasures to include prophylaxes, pretreatments, antidotes, skin decontaminants, and therapeutic drugs against identified and emerging biological and chemical warfare agents. Medical Science and Technology (S&T) efforts in this Budget Activity refine promising medical initiatives identified in Budget Activity 1, resulting in the development of countermeasures to protect against and treat the effects of exposure to chemical and biological (CB) agents. Diagnostic research focuses on providing high quality data closer to the point-of-need comprising devise innovation, panels of biomarkers driven by bioinformatics, and epidemiological modeling tools. The Medical Countermeasures Initiative (MCMI) was established to coordinate inter-related advanced development and flexible manufacturing capabilities, providing a dedicated, cost-effective, reliable, and sustainable MCM process that meets the Warfighter and national security needs. MCMI efforts within science and technology (S&T) are concentrated in advancing two areas: 1) regulatory science and 2) flexible manufacturing technologies and processes for MCMs. Efforts conducted in these areas are enablers supporting the DoD Medical Countermeasures Advanced Development and Manufacturing (MCM-ADM) capability. In FY13, all Project TB2 research was re-aligned into Project TM2 - Techbase Medical Defense.
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2015
- Source ID
- TM2_0602384BP_2_0400_PB_2015
Related Documents
- Root: CHEMICAL/BIOLOGICAL DEFENSE (APPLIED RESEARCH)
- Child Accomplishment: 1) Techbase Med Defense - Diagnostics
- Child Accomplishment: 2) Chemical Diagnostics
- Child Accomplishment: 3) Diagnostic Assays
- Child Accomplishment: 4) Diagnostic Technologies
- Child Accomplishment: 5) Next Generation Diagnostics
- Child Accomplishment: 6) Medical Countermeasures Initiative
- Child Accomplishment: 7) Bacterial/Toxins Vaccines
- Child Accomplishment: 8) Vaccine Platforms and Research Tools
- Child Accomplishment: 9) Viral Therapeutics
- Child Accomplishment: 10) Bacterial Therapeutics
- Child Accomplishment: 11) Toxin Therapeutics
- Child Accomplishment: 12) Multiagent Medical Countermeasures
- Child Accomplishment: 13) Pretreatments, Nerve Agents
- Child Accomplishment: 14) Cutaneous/Ocular Therapeutics
- Child Accomplishment: 15) Chemical Therapeutics
- Child Accomplishment: 16) Radiation Countermeasures